These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3960887)

  • 21. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 22. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 5: An evaluation of the genetic toxicity of dichlorvos.
    Ramel C; Drake J; Sugimura T
    Mutat Res; 1980 Nov; 76(3):297-309. PubMed ID: 6782471
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic toxicology in industry: perspectives and initiatives.
    Ashby J
    Prog Clin Biol Res; 1986; 208():89-94. PubMed ID: 3960894
    [No Abstract]   [Full Text] [Related]  

  • 25. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic risk assessment of germ-line mutations. Introduction.
    Ehling UH
    Genome; 1989; 31(2):841-3. PubMed ID: 2632352
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selection and application of mutagenicity tests in identification of carcinogens and mutagens. (II)].
    Wang JN
    Zhonghua Yu Fang Yi Xue Za Zhi; 1983 Sep; 17(5):313-5. PubMed ID: 6689553
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiology of occupational carcinogens and mutagens.
    Ruder AM
    Occup Med; 1996; 11(3):487-512. PubMed ID: 8887381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent aspects of mutagenicity tests on chemicals in our environment (author's transl)].
    Ishidate M; Yoshikawa K; Sofuni T
    Eisei Shikenjo Hokoku; 1980; 98():1-19. PubMed ID: 7018634
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of individuals at risk: cytogenetic and molecular methods.
    Scott D; Heighway J
    Prog Clin Biol Res; 1986; 209B():205-12. PubMed ID: 3749077
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard.
    Silva Lima B; Van der Laan JW
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):135-43. PubMed ID: 11067770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings of the British Toxicology Society. York, 24-25 March 1988. Joint British Toxicology Society, United Kingdom Environmental Mutagen Society Symposium. Abstracts.
    Hum Toxicol; 1988 Jul; 7(4):367-84. PubMed ID: 3410488
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of cytotoxicity on test results in the L5178Y TK+/- mouse lymphoma assay.
    Oberly TJ; Garriot ML
    Environ Mol Mutagen; 1996; 27(1):75-8. PubMed ID: 8625951
    [No Abstract]   [Full Text] [Related]  

  • 34. Workshop on the relationship between short-term information and carcinogenicity; Williamsburg, Virginia, January 20-23, 1987.
    Auletta A; Ashby J
    Environ Mol Mutagen; 1988; 11(1):135-45. PubMed ID: 2892674
    [No Abstract]   [Full Text] [Related]  

  • 35. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9.
    Scott D; Galloway SM; Marshall RR; Ishidate M; Brusick D; Ashby J; Myhr BC
    Mutat Res; 1991 Mar; 257(2):147-205. PubMed ID: 2005937
    [No Abstract]   [Full Text] [Related]  

  • 36. Extending the threshold of regulation concept: de minimis limits for carcinogens and mutagens.
    Fiori JM; Meyerhoff RD
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):209-16. PubMed ID: 12052005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for screening for potential human germ cell mutagens: an ICPEMC Working Paper.
    Bridges BA; Mendelsohn ML
    Prog Clin Biol Res; 1986; 209B():51-65. PubMed ID: 3749105
    [No Abstract]   [Full Text] [Related]  

  • 38. International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for combining and comparing short-term genotoxicity test data: preface. A report from ICPEMC Committee 1.
    Brusick DJ; Ashby J; de Serres FJ; Lohman PH; Matsushima T; Matter BE; Mendelsohn ML; Moore DH; Nesnow S; Waters MD
    Mutat Res; 1992 Mar; 266(1):1-6. PubMed ID: 1372961
    [No Abstract]   [Full Text] [Related]  

  • 39. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays.
    Gaylor DW; Gold LS
    Regul Toxicol Pharmacol; 1995 Aug; 22(1):57-63. PubMed ID: 7494904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines on the use of mutagenicity tests in the toxicological evaluation of chemicals. A report of the DNH&W/DOE Envionmental Contaminants Advisory Committee on Mutagenesis.
    Environ Mol Mutagen; 1988; 11(2):261-304. PubMed ID: 3345740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.